DarioHealth (DRIO) Revenue (2014 - 2026)

DarioHealth (DRIO) has reported Revenue for 13 consecutive years, with $5.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue fell 3.58% year-over-year to $5.2 million; the trailing twelve-month figure through Jun 2026 stood at $21.0 million (down 22.65% YoY), and the FY2025 full-year result was $22.4 million, down 17.31% from the prior year.
• Revenue fell to $5.2 million in Q2 2026 per DRIO's latest filing, from $5.6 million in the prior quarter.
• Across five years, Revenue topped out at $8.1 million in Q1 2022 and bottomed at $3.5 million in Q3 2023.
• Historically, Revenue has averaged $6.0 million across 5 years, with a median of $6.2 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Revenue soared 124.17% in 2022, then sank 46.89% in 2023.
• Over 5 years, Revenue stood at $6.8 million in 2022, then tumbled by 46.89% to $3.6 million in 2023, then jumped by 110.29% to $7.6 million in 2024, then plunged by 31.21% to $5.2 million in 2025, then decreased by 1.03% to $5.2 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $5.2 million, $5.6 million, and $5.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.